Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a Body Corporate”

252 pharma patents match "The Regents of the University of Colorado, a Body Corporate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 6 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "The Regents of the University of Colorado, a Body Corporate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “The Regents of the University of Colorado, a Body Corporate” · 30,257 patents in full index Clear search

  1. US 10233222

    Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  2. US 10233235

    Modulating the alternative complement pathway

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  3. US 10232035

    Conditionally replication deficient herpes virus and use thereof in vaccines

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  4. US 10221226

    LEDGF peptides and formulations thereof for treatment of degenerative disorders

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  5. US 10221222

    Dermaseptin-type and piscidin-type antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  6. US 10214487

    Indole derivatives and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  7. US 10202397

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  8. US 10160962

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  9. US 10155020

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  10. US 10130604

    Composition and method for treating neurodegenerative disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  11. US 10117915

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  12. US 10111861

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  13. US 10080376

    Method for enhancing postprocessing content of beneficial compounds in beverages naturally containing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  14. US 10076520

    Use of tyrosine kinase inhibitor in cancer treatment

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  15. US 10052393

    Multifunctional nanomaterials for the treatment of cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  16. US 10046036

    Chemically modified cystathionine β-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  17. US 9994901

    Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  18. US 9980634

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted May 29, 2018 · Expires May 24, 2038

    granted

  19. US 9949484

    Antimicrobial polyurethane materials and methods of forming and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  20. US 9950044

    Treatment of pulmonary vascular remodeling with neprilysin

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  21. US 9949928

    Biodegradable copolymers, systems including the copolymers, and methods of forming and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  22. US 9938353

    Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  23. US 9895420

    IL-1beta propeptide and IL-1Ra chimera and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  24. US 9884096

    Compositions and methods related to graft versus host disease and treatments thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.